Literature DB >> 31250884

Sub-dominant principal components inform new vaccine targets for HIV Gag.

Syed Faraz Ahmed1, Ahmed A Quadeer1, David Morales-Jimenez2, Matthew R McKay1,3.   

Abstract

MOTIVATION: Patterns of mutational correlations, learnt from patient-derived sequences of human immunodeficiency virus (HIV) proteins, are informative of biochemically linked networks of interacting sites that may enable viral escape from the host immune system. Accurate identification of these networks is important for rationally designing vaccines which can effectively block immune escape pathways. Previous computational methods have partly identified such networks by examining the principal components (PCs) of the mutational correlation matrix of HIV Gag proteins. However, driven by a conservative approach, these methods analyze the few dominant (strongest) PCs, potentially missing information embedded within the sub-dominant (relatively weaker) ones that may be important for vaccine design.
RESULTS: By using sequence data for HIV Gag, complemented by model-based simulations, we revealed that certain networks of interacting sites that appear important for vaccine design purposes are not accurately reflected by the dominant PCs. Rather, these networks are encoded jointly by both dominant and sub-dominant PCs. By incorporating information from the sub-dominant PCs, we identified a network of interacting sites of HIV Gag that associated very strongly with viral control. Based on this network, we propose several new candidates for a potent T-cell-based HIV vaccine.
AVAILABILITY AND IMPLEMENTATION: Accession numbers of all sequences used and the source code scripts for all analysis and figures reported in this work are available online at https://github.com/faraz107/HIV-Gag-Immunogens. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31250884     DOI: 10.1093/bioinformatics/btz524

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  6 in total

1.  Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques.

Authors:  Dariusz K Murakowski; John P Barton; Lauren Peter; Abishek Chandrashekar; Esther Bondzie; Ang Gao; Dan H Barouch; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

2.  Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.

Authors:  Syed Faraz Ahmed; Ahmed A Quadeer; Matthew R McKay
Journal:  Viruses       Date:  2020-02-25       Impact factor: 5.048

Review 3.  In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives.

Authors:  Muhammad Saqib Sohail; Syed Faraz Ahmed; Ahmed Abdul Quadeer; Matthew R McKay
Journal:  Adv Drug Deliv Rev       Date:  2021-01-17       Impact factor: 17.873

4.  Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-CoV-2.

Authors:  Ang Gao; Zhilin Chen; Assaf Amitai; Julia Doelger; Vamsee Mallajosyula; Emily Sundquist; Florencia Pereyra Segal; Mary Carrington; Mark M Davis; Hendrik Streeck; Arup K Chakraborty; Boris Julg
Journal:  iScience       Date:  2021-03-15

5.  Evolutionary modeling reveals enhanced mutational flexibility of HCV subtype 1b compared with 1a.

Authors:  Hang Zhang; Ahmed A Quadeer; Matthew R McKay
Journal:  iScience       Date:  2021-12-08

6.  Predicting the Immunogenicity of T cell epitopes: From HIV to SARS-CoV-2.

Authors:  Ang Gao; Zhilin Chen; Florencia Pereyra Segal; Mary Carrington; Hendrik Streeck; Arup K Chakraborty; Boris Julg
Journal:  bioRxiv       Date:  2020-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.